Gilde Healthcare picks up Sanquin Reagents
Sanquin Reagents is the first investment of Gilde Healthcare's €517 million Private Equity Fund IV.
30 August 2022•2 mins read
Sanquin Reagents is the first investment of Gilde Healthcare's €517 million Private Equity Fund IV.
Phoenix Equity’s Nineteen Group acquires exhibitions organizer Blueprint Event Company
12 hours ago · 1 min read
Platinum Equity seals deal for Chicago propane distributor EDP
12 hours ago · 2 mins read
Industrial Growth Partners inks sale of AdvancedPCB to Amphenol
13 hours ago · 2 mins read
Avance-backed Alchemy Technology Group buys Austin cybersecurity provider Freeit Data Solutions
13 hours ago · 1 min read
A&M Capital buys majority stake in insurance investigations firm Delta Group
13 hours ago · 2 mins read
Hunter Point Capital provides preferred financing to Denver’s Bow River Capital
16 hours ago · 2 mins read
OceanSound-backed Burns Engineering buys district energy engineering firm PRVN Consultants
16 hours ago · 1 min read
